LMG Life Sciences Awards EMEA 2025: open for entries

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2025: open for entries

Copy of EMEA awards 2024-Shortlist Announced-1200x627.png

It is time to submit nominations for the sixth annual Life Sciences Awards EMEA

The 2025 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.

As ever, the Awards will recognise excellence in the life sciences legal market, showcasing the law firms, lawyers, in-house legal teams, and legal work that moved the dial in Europe, the Middle East & Africa's life sciences industry in 2024.

The deadline for entries is January 30 2025.

ENTRY FORMS

AWARDS GUIDELINES

ENTRY PORTAL

FAQs

Important Dates:

Entries Open

Entry Deadline

Shortlist Published

Gala Ceremony

December 18 2024

January 30 2025

March 2025

June 2025


All nominations must be entered through our Entry Portal. Nominations made in any other format or emailed to us will not be accepted.

For any questions about the awards or the research, please contact Life Sciences Awards editor Alex Griffiths or EMEA Research Director James Wilson.

LMG Life Sciences Awards

The LMG Life Sciences EMEA Awards recognise leading law firms and lawyers who specialise in the life sciences industry throughout the Europe, the Middle East and Africa.

The ceremony will celebrate outstanding legal work over the previous calendar year, showcasing firms and lawyers who are moving the dial for the life sciences industry. The award’s distinctive structure highlights firms and individuals that specialise in practice areas within life sciences.

LMG Life Sciences is a sister publication of Managing IP and works in collaboration with IFLR, Managing IP, and Benchmark Litigation to identify the best of the best from across the industry.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article